Outpatient Administration of Teclistamab for Multiple Myeloma
Condition:   Multiple Myeloma Interventions:   Drug: Teclistamab;   Drug: Tocilizumab Sponsors:   SCRI Development Innovations, LLC;   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials